Dylan Harrell, MD
Pulmonary Disease · Shreveport, LANPI 1679936769
Payments from drug & device makers
Across 102 payments — averaging $38.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Olympus America Inc.$494
- GSK$375
- AstraZeneca$331
- Shionogi Inc$217
- Actelion Pharmaceuticals US, Inc.$127
- plus $923 from 24 others
What the payments were for
- Travel & lodging$1,33434%
- Food & beverage$2,62866%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 9 | $1,495 |
| Olympus America Inc. | 5 | $494 |
| GSK | 15 | $375 |
| AstraZeneca | 19 | $331 |
| Shionogi Inc | 2 | $217 |
| Actelion Pharmaceuticals US, Inc. | 6 | $127 |
| Sanofi | 4 | $123 |
| Regeneron Healthcare Solutions, Inc. | 5 | $96 |
| Merck | 4 | $79 |
| Insmed, Inc. | 4 | $74 |
| Body Vision Medical Inc. | 1 | $72 |
| Gyrus ACMI, Inc. | 1 | $60 |
| Genentech USA, Inc. | 3 | $48 |
| Jazz Pharmaceuticals Inc. | 2 | $46 |
| Electromed, Inc. | 6 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Pinnacle Biologics, Inc | 1 | $28 |
| Bayer | 1 | $26 |
| AbbVie | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Verona Pharma, Inc. | 1 | $18 |
| Abiomed | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Philips North America LLC | 1 | $16 |
| Regeneron | 1 | $15 |
| Recordati_rare_diseases_inc. | 1 | $14 |
| Pharmacosmos Therapeutics Inc. | 1 | $14 |
| Rigel Pharmaceuticals, Inc. | 1 | $14 |
| EMD Serono, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,406
- Spiration Valve System$260
- Fetroja$124
- NUCALA$104
How this compares
$3,962 in reported general payments places this provider in the 45th percentile of 189 pulmonary disease providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $1,068 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Shreveport
- David GreenShreveport$2M
- Afsana AsharafShreveport$118K
- Robert HolladayShreveport$71K
- Prathik KrishnanShreveport$34K
- Himanshu DesaiShreveport$23K
- Scott HowardShreveport$20K
- Richard KammShreveport$15K
- David ChambersShreveport$13K
- Ahmed ViraniShreveport$12K
- Joseph LaskyNew Orleans$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.